Houzz Logo Print
anniedeighnaugh

Now for some good news!

6 years ago

Source: CNBC

  • White House health advisor Dr. Anthony Fauci said Wednesday that data from a coronavirus drug trial testing Gilead Sciences’ antiviral drug remdesivir showed “quite good news” and sets a new standard of care for Covid-19 patients.
  • Fauci said the median time of recovery for patients taking the drug was 11 days, compared with 15 days in the placebo group.
  • The results suggested a survival benefit, with a mortality rate of 8% for the group receiving remdesivir versus 11.6% for the placebo group, according to a statement from the National Institutes of Health released later Wednesday.

It's a long way from a solid treatment, but it's better than nothing, and it may point the way to even more effective treatments.

Fingers crossed!

Comments (7)

Sponsored
Buckeye Basements, Inc.
Average rating: 5 out of 5 stars40 Reviews
Central Ohio's Basement Finishing ExpertsBest Of Houzz '13-'21